Antiobesity Effects of Anthocyanins in Preclinical and Clinical Studies

Elena Azzini1, Jasminka Giacometti2, Gian Luigi Russo3

  • 1Council for Agricultural Research and Economics (CREA), Research Center for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy.

Insights

Anthocyanins, natural compounds in foods, show potential for weight management and reducing adipose tissue. However, research highlights challenges in dosage, metabolism, and interactions, necessitating better models for effective obesity treatment.

Area of Science:

  • Nutritional Science
  • Biochemistry
  • Pharmacology

Background:

  • Natural phytochemicals, such as anthocyanins, are investigated for their potential anti-obesity effects.
  • Obesity and its associated comorbidities are significant global health concerns.

Purpose of the Study:

  • To review current knowledge on anthocyanins' role in obesity and related conditions.
  • To summarize mechanisms of action, target identification, and health effects of anthocyanins.

Main Methods:

  • Comprehensive literature review of studies on anthocyanins, obesity, and comorbidities.
  • Analysis of data from animal models and human clinical trials.
  • Examination of metabolic pathways and interactions of anthocyanins.

Main Results:

  • Anthocyanin supplementation shows promise but faces challenges similar to other phytochemicals.
  • Dosage discrepancies between animal and human studies complicate interpretation.
  • Complex metabolism and potential interactions among supplemented compounds affect outcomes.

Conclusions:

  • The efficacy of anthocyanins for obesity is influenced by dosage, metabolism, and interactions.
  • Further research requires improved cellular and animal models for targeted clinical studies.
  • Distinguishing between prevention and therapy is crucial for future anthocyanin research.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
247
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K